For the Inventor, By the Inventor

Enter assignee name

Shenzhen, China

Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd.

USPTO Granted Patents = 4

EPO Patents = 1

Forward Citations = 1

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Tian Tang (4 out of 4 patents)

Jing Wu (3 out of 16 patents)

Yanqing Wang (3 out of 3 patents)

4. Hanlin Feng (3 out of 5 patents)

5. Tao Shi (2 out of 2 patents)

6. Jing'an Yang (2 out of 2 patents)

7. Lin Yu (2 out of 5 patents)

8. Jin Wang (1 out of 8 patents)

9. Zhiying Huang (1 out of 1 patent)

10. Yanping Chen (1 out of 1 patent)

11. Xiaorou Liu (1 out of 2 patents)

12. Ruyi Jin (1 out of 1 patent)

13. Feng Jin (1 out of 3 patents)

14. Xiarou Liu (1 out of 1 patent)

15. Hanmin Huang (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12391706 - Multi-target tyrosine kinase inhibitor (2025-08-19),

2. 11192882 - Crystal form of small molecule immune compound, preparation method thereof and pharmaceutical composition containing the same (2021-12-07),

3. 10640492 - Tubulin inhibitor (2020-05-05),

4. 9957237 - Crystal form of neptinib di-p-methylbenzenesulfonate, preparation method thereof, and pharmaceutical composition containing same (2018-05-01),

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#865 in

#5,594 in

Shenzhen, China

Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd.

Forward Citations = 1

17 inventors:

Tian Tang (4 out of 4 patents)

Jing Wu (3 out of 16 patents)

Yanqing Wang (3 out of 3 patents)

4. Hanlin Feng (3 out of 5 patents)

5. Tao Shi (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…